375 related articles for article (PubMed ID: 34893936)
1. Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review.
Shi Q; Li F; Yeh S; Moinuddin SM; Xin J; Xu J; Chen H; Ling B
AAPS PharmSciTech; 2021 Dec; 23(1):16. PubMed ID: 34893936
[TBL] [Abstract][Full Text] [Related]
2. A mechanistic review on the dissolution phase behavior and supersaturation stabilization of amorphous solid dispersions.
Ashwathy P; Anto AT; Sudheesh MS
Drug Dev Ind Pharm; 2021 Jan; 47(1):1-11. PubMed ID: 33494623
[TBL] [Abstract][Full Text] [Related]
3. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
Baghel S; Cathcart H; O'Reilly NJ
Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
[TBL] [Abstract][Full Text] [Related]
4. Supersaturation, nucleation, and crystal growth during single- and biphasic dissolution of amorphous solid dispersions: polymer effects and implications for oral bioavailability enhancement of poorly water soluble drugs.
Sarode AL; Wang P; Obara S; Worthen DR
Eur J Pharm Biopharm; 2014 Apr; 86(3):351-60. PubMed ID: 24161655
[TBL] [Abstract][Full Text] [Related]
5. Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption.
Guan J; Jin L; Liu Q; Xu H; Wu H; Zhang X; Mao S
Eur J Pharm Sci; 2019 Nov; 139():105043. PubMed ID: 31415903
[TBL] [Abstract][Full Text] [Related]
6. The influence of polymer excipients on the dissolution and recrystallization behavior of ketoconazole: Application, variation and practical aspects of a pH shift method.
Ullrich A; Schiffter HA
Eur J Pharm Biopharm; 2018 Dec; 133():20-30. PubMed ID: 30261267
[TBL] [Abstract][Full Text] [Related]
7. Co-amorphous Drug Delivery Systems: a Review of Physical Stability, In Vitro and In Vivo Performance.
Shi Q; Wang Y; Moinuddin SM; Feng X; Ahsan F
AAPS PharmSciTech; 2022 Sep; 23(7):259. PubMed ID: 36123515
[TBL] [Abstract][Full Text] [Related]
8. Recent Technologies for Amorphization of Poorly Water-Soluble Drugs.
Kim DH; Kim YW; Tin YY; Soe MT; Ko BH; Park SJ; Lee JW
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452279
[TBL] [Abstract][Full Text] [Related]
9. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
Widanapathirana L; Tale S; Reineke TM
Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
[TBL] [Abstract][Full Text] [Related]
10. Oral bioavailability enhancement of β-lapachone, a poorly soluble fast crystallizer, by cocrystal, amorphous solid dispersion, and crystalline solid dispersion.
Liu C; Liu Z; Chen Y; Chen Z; Chen H; Pui Y; Qian F
Eur J Pharm Biopharm; 2018 Mar; 124():73-81. PubMed ID: 29305142
[TBL] [Abstract][Full Text] [Related]
11. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
[TBL] [Abstract][Full Text] [Related]
12. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
Jackson MJ; Kestur US; Hussain MA; Taylor LS
Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
[TBL] [Abstract][Full Text] [Related]
13. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in co-amorphous drug formulations.
Dengale SJ; Grohganz H; Rades T; Löbmann K
Adv Drug Deliv Rev; 2016 May; 100():116-25. PubMed ID: 26805787
[TBL] [Abstract][Full Text] [Related]
15. Development of an Amorphous Solid Dispersion Formulation for Mitigating Mechanical Instability of Crystalline Form and Improving Bioavailability for Early Phase Clinical Studies.
Chiang CW; Lubach JW; Chen T; Chin S; Ly J; Zhang W; Hou HH; Nagapudi K
Mol Pharm; 2023 May; 20(5):2452-2464. PubMed ID: 37010134
[TBL] [Abstract][Full Text] [Related]
16. Microdialysis and nanofiltration allow to distinguish molecularly dissolved from colloid-associated drug concentrations during biomimetic dissolution testing of supersaturating formulations.
Holzem FL; Schaffland JP; Brandl M; Bauer-Brandl A; Stillhart C
Eur J Pharm Sci; 2022 Jul; 174():106166. PubMed ID: 35283259
[TBL] [Abstract][Full Text] [Related]
17. Ternary Solid Dispersions: A Review of the Preparation, Characterization, Mechanism of Drug Release, and Physical Stability.
Budiman A; Lailasari E; Nurani NV; Yunita EN; Anastasya G; Aulia RN; Lestari IN; Subra L; Aulifa DL
Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631330
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Understanding the Micro- and Nanoscale Phenomena of Amorphous Solid Dispersions.
Ricarte RG; Van Zee NJ; Li Z; Johnson LM; Lodge TP; Hillmyer MA
Mol Pharm; 2019 Oct; 16(10):4089-4103. PubMed ID: 31487183
[TBL] [Abstract][Full Text] [Related]
19. Combined Effects of Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble Poly(2-hydroxyethyl methacrylate) Hydrogels.
Schver GCRM; Lee PI
Mol Pharm; 2018 May; 15(5):2017-2026. PubMed ID: 29601723
[TBL] [Abstract][Full Text] [Related]
20. Emerging trends in the stabilization of amorphous drugs.
Laitinen R; Löbmann K; Strachan CJ; Grohganz H; Rades T
Int J Pharm; 2013 Aug; 453(1):65-79. PubMed ID: 22569230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
